Skip to content

ESAB ESAB Capitalized R&D costs

Capitalized R&D costs at other companies

Curtiss-Wright logo
Curtiss-WrightCW
$52.53M-13.6%
Honeywell International logo
Honeywell InternationalHON
$917M-3.1%
Parker-Hannifin logo
Parker-HannifinPH
$172M+17.8%
Hubbell logo
HubbellHUBB
$32.5M-42.2%
L3Harris Technologies logo
L3Harris TechnologiesLHX
$1.25B-26.5%
Kimberly-Clark logo
Kimberly-ClarkKMB
$204M-25.0%

Other financials

Income statement

See full
Revenue$745.6M+9.9%
Gross profit$275.1M+7.8%
Operating income$90.5M-17.6%
Net income$47.6M-29.3%
EPS (diluted)$0.78-29.1%

Balance sheet

See full
Cash & equivalents$1.0B+245%
Total debt$2.1B+84.9%
Total equity$2.2B+14.7%
Total assets$5.6B+33.4%

Cash flow

See full
Operating cash flow$46.9M+32.5%
CapEx$13.7M+87.9%
Free cash flow$33.2M+18.1%

Valuation

See full
Market cap$6.47B-16.7%
Enterprise value$7.6B-11.5%
P/E31.2×+2.7×
P/S2.2×-0.6×

Profitability

See full
Gross margin36.7%-1.3pp
Operating margin13.5%-2.9pp
Net margin7.1%-2.9pp
FCF margin7.5%-3.3pp

Returns & leverage

See full
Return on equity10.1%-5.2pp
Debt / equity+0.4×
Current ratio+1.1×

Where this comes from

Reported directly by ESAB in its filing.

Tagged under the XBRL concept esab:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsCapitalizedResearchAndDevelopmentCosts.

The official record: ESAB’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about ESAB's capitalized r&d costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ESAB's capitalized r&d costs?
ESAB (ESAB) reported capitalized r&d costs of $22.04M in Q4 2025.
What is the long-term trend for ESAB's capitalized r&d costs?
Over 3 years (2022 to 2025), ESAB's capitalized r&d costs has grown at a 15.9% compound annual growth rate (CAGR), from $14.16M to $22.04M.
What does capitalized r&d costs mean?
This represents the portion of research and development expenditures that have been capitalized as assets rather than expensed immediately in the period incurred. It reflects the company's investment in future product innovation and technological capabilities. Tracking this helps investors understand the company's commitment to long-term growth and the potential for future competitive advantages.